1. Home
  2. PWUP vs ELTX Comparison

PWUP vs ELTX Comparison

Compare PWUP & ELTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PWUP
  • ELTX
  • Stock Information
  • Founded
  • PWUP 2021
  • ELTX 2011
  • Country
  • PWUP United States
  • ELTX United States
  • Employees
  • PWUP N/A
  • ELTX N/A
  • Industry
  • PWUP Blank Checks
  • ELTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • PWUP Finance
  • ELTX Health Care
  • Exchange
  • PWUP Nasdaq
  • ELTX Nasdaq
  • Market Cap
  • PWUP 87.4M
  • ELTX 80.4M
  • IPO Year
  • PWUP 2022
  • ELTX 2021
  • Fundamental
  • Price
  • PWUP $11.21
  • ELTX $4.69
  • Analyst Decision
  • PWUP
  • ELTX Buy
  • Analyst Count
  • PWUP 0
  • ELTX 2
  • Target Price
  • PWUP N/A
  • ELTX $10.00
  • AVG Volume (30 Days)
  • PWUP 209.0
  • ELTX 72.7K
  • Earning Date
  • PWUP 01-01-0001
  • ELTX 08-09-2024
  • Dividend Yield
  • PWUP N/A
  • ELTX N/A
  • EPS Growth
  • PWUP N/A
  • ELTX N/A
  • EPS
  • PWUP 0.18
  • ELTX N/A
  • Revenue
  • PWUP N/A
  • ELTX N/A
  • Revenue This Year
  • PWUP N/A
  • ELTX N/A
  • Revenue Next Year
  • PWUP N/A
  • ELTX N/A
  • P/E Ratio
  • PWUP $62.50
  • ELTX N/A
  • Revenue Growth
  • PWUP N/A
  • ELTX N/A
  • 52 Week Low
  • PWUP $10.07
  • ELTX $2.96
  • 52 Week High
  • PWUP $13.70
  • ELTX $11.45
  • Technical
  • Relative Strength Index (RSI)
  • PWUP 37.57
  • ELTX 42.30
  • Support Level
  • PWUP $11.26
  • ELTX $4.12
  • Resistance Level
  • PWUP $11.69
  • ELTX $4.99
  • Average True Range (ATR)
  • PWUP 0.00
  • ELTX 0.54
  • MACD
  • PWUP 0.00
  • ELTX 0.17
  • Stochastic Oscillator
  • PWUP 0.00
  • ELTX 81.76

About PWUP PowerUp Acquisition Corp.

PowerUp Acquisition Corp is a blank check company. It is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.

Share on Social Networks: